Company profile: Evergreen Theragnostics
1.1 - Company Overview
Company description
- Provider of radiopharmaceutical contract development and manufacturing services, covering early-stage development through commercial production. The company develops and commercializes radiopharmaceuticals (e.g., Ga-68 DOTATOC), discovers novel radiopharmaceuticals for unmet clinical needs in cancer treatment, and operates an Alpha Therapy Line for GMP Ac-225 products and a Springfield facility compliant with US FDA 21 CFR 211 and EMA cGMP.
Products and services
- Alpha Therapy Line: A dedicated GMP-compliant suite constructs alpha-emitting radiopharmaceuticals using Ac-225, supporting manufacture from early clinical phases through commercial supply volumes
- CDMO Services: Evergreen Theragnostics delivers commercial-scale contract development and manufacturing for radiopharmaceuticals, covering early-stage development through commercial production for U.S. clients
- Radiopharmaceutical Product Development: Evergreen Theragnostics architects Ga-68-based radiopharmaceutical product development and commercialization, including Ga-68 DOTATOC, as a U.S. CDMO specializing in radiopharmaceuticals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evergreen Theragnostics
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
ProBioGen
HQ: Germany
Website
- Description: Provider of contract development and manufacturing and technology services for biopharmaceuticals, specializing in cell line engineering, scalable upstream and downstream process development, GMP manufacturing, and virus production. Offers development and manufacturing of therapeutic proteins and antibodies, custom stable production cell lines, and support for biosimilars and biobetters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProBioGen company profile →
Medicus Pharma
HQ: Canada
Website
- Description: Provider of biotechnology research services that accelerate life sciences and biotech companies through FDA clinical trials, via clinical development programs spanning clinical evaluation, regulatory approval, and market introduction. Through Skinject Inc., develops a dissolvable doxorubicin microneedle patch for non-melanoma skin cancer, particularly basal cell carcinoma. Pursues acquisitions and partnerships to expand its drug development pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicus Pharma company profile →
EirGen Pharma
HQ: Ireland
Website
- Description: Provider of high potency oral solid dose medicines for human and veterinary use and contract development, manufacturing, and packaging services for the global pharmaceutical market, including research, formulation, and analytical development and investigational medicinal products. Fully licensed to manufacture oncology, cytotoxic, steroidal, and immunosuppressant molecules in purpose-built high containment suites, covering film-coated tablets, soft-gel, and hard-shell capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EirGen Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evergreen Theragnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evergreen Theragnostics
2.2 - Growth funds investing in similar companies to Evergreen Theragnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evergreen Theragnostics
4.2 - Public trading comparable groups for Evergreen Theragnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →